• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Naturvetenskap och teknik
    2. Matematik och naturvetenskap
    3. Biologi
    4. Cellbiologi

    Gene and Cell Therapy

    Therapeutic Mechanisms and Strategies

    AvGraca Almeida-Porada,Anthony Atala

    Inbunden, Engelska, 2026

    4 080 kr

    Slutsåld

    Beskrivning

    The most comprehensive, state-of-the-art book on using gene and cell therapy in clinical medicine, Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Fifth Edition, presents extensive background and basic information, cutting edge technologies, important achievements, and lingering challenges in the fields of gene and cell therapies. The fifth edition of this bestseller continues to provide the most comprehensive coverage of these fields in one volume. Some chapters have expanded introductions, making the book even more suitable for classroom use. This edition also offers more material on the contributors’ research efforts as well as current technologies, disease targets, and clinical applications.Divided into three sections, the book covers:Delivery systems and therapeutic strategiesOther therapeutic strategies, including technologies that knock down gene expressionGene expression, regulation, and detectionGene and cell therapies, disease targets, clinical trials, and regulatory issuesAccessible to a broad audience, including students, scientists, physicians, and lay people, this book provides readers with up-to-date, interdisciplinary knowledge and tools to tackle the evolving areas of gene therapy, cell therapy, and tissue engineering. From introductory information to novel technologies and concepts, the book helps readers understand vector design and construction, delivery systems, therapeutic strategies, gene expression and detection, disease targets, clinical applications and trials, cell-based therapies, novel imaging systems, gene regulation, and regulatory affairs.

    Produktinformation

    • Utgivningsdatum:2026-09-18
    • Mått:210 x 280 x undefined mm
    • Vikt:453 g
    • Format:Inbunden
    • Språk:Engelska
    • Antal sidor:472
    • Upplaga:5
    • Förlag:Taylor & Francis Ltd
    • ISBN:9780367771799

    Utforska kategorier

    • Cellbiologi inom Naturvetenskap och teknik
    • Biovetenskap inom Naturvetenskap och teknik
    • Biologi inom Naturvetenskap och teknik

    Mer om författaren

    Dr Graça Almeida-Porada earned her MD and her PhD from the School of Medicine and Biomedical Sciences at the University of Porto, Portugal. She is currently a professor and the Director of the Fetal Research and Therapy Program at the Wake Forest Institute for Regenerative Medicine. She is also a professor in the Department of Internal Medicine, Section of Hematology and Oncology, and School of Biomedical Engineering and Sciences, Wake Forest School of Medicine. Dr Almeida-Porada’s research focuses on the development of cellular and gene delivery platforms to treat genetic and immune-mediated diseases. She is particularly interested in improving the outcome of stem cell transplantation and gene therapy in fetal and neonatal patients with genetic disorders, and in developing therapies for children with immunemediated diseases. She is the co-founder of the International Fetal Transplantation and Immunology Society, whose mission is to accelerate clinical applications of stem cell transplantation and gene therapy approaches to treat fetuses with congenital disorders. Dr Almeida-Porada serves on numerous review panels, study sections, and professional and scientific committees, and she is a reviewer for many peer-reviewed journals. She has been a member of several NIH study sections, and she serves as an editor, or on the editorial boards, of multiple scientific journals and book series. Dr Almeida-Porada also serves on the scientific advisory boards for several ongoing prenatal clinical trials, both in the US and in Europe. Dr Almeida-Porada holds several patents, and she has authored more than 300 scientific works including papers, abstracts, and book chapters.Dr Anthony Atala is a practicing surgeon and the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine. His work focuses on bioprinting and growing human cells, tissues, and organs. Seventeen applications of technologies developed in Dr Atala’s laboratory have been used clinically. Dr Atala was elected to the National Academy of Medicine, the National Academy of Inventors, and the American Institute for Medical and Biological Engineering. He is a recipient of the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society, the World Technology Award in Health and Medicine, the Edison Science/Medical Award, the R&D Innovator of the Year Award, and the Smithsonian Ingenuity Award. Dr Atala’s work was listed twice as Time Magazine’s top 10 medical breakthroughs of the year, as one of five discoveries that will change the future of organ transplants and was ranked by the Project Management Institute as one of the top 10 most impactful biotech projects from the past 50 years. Dr Atala was named by Scientific American as one of the world’s most influential people in biotechnology, by U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century, by Life Sciences Intellectual Property Review as one of 50 key influencers in the life sciences intellectual property arena, and by the journal Nature Biotechnology as one of the top 10 translational researchers in the world. Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He was a founder of the Tissue Engineering Society, the Regenerative Medicine Society, the Regenerative Medicine Foundation, the Alliance for Regenerative Medicine, the Regenerative Medicine Development Organization, the Regenerative Medicine Manufacturing Society, and the Regenerative Medicine Manufacturing Consortium. Dr Atala is editor of 25 books and 2 journals, has published more than 900 journal articles, and has applied for or received over 300 national and international patents.

    Innehållsförteckning

    • About the EditorsList of ContributorsPrefaceSection I Gene Therapy1. Biology and Immunology of Recombinant Adeno-Associated Viral Vectors in Gene Therapy2. Alphavirus Vectors in Gene Therapy and Neuroscience3. Gene Electrotransfer4. Evolution of Polyplexes: Refining Structural Motifs Required for Nucleic Acid Delivery5. Therapeutic Applications of Morpholino Oligonucleotides6. Nonviral Genome Modification Strategies for Gene Therapy: Transposon, Integrase, and Nuclease Systems7. Complex In Vitro Models and Their Application in Gene Editing Technologies 8. Gene Therapy for Vision DisordersSection II Cell Therapies9. Therapies with Adipose Tissue-Derived Stem/Stromal Cells 10. Placenta-Derived Stem Cells and Their Therapeutic Applications 11. Cell-Based Therapies from Umbilical Cord Blood12. Cell Therapies for the Treatment of Hepatic Inborn Metabolic Errors 13. Cell Therapies for Gastrointestinal Diseases14. Cell Therapies for Genitourinary Disorders15. Translating Stem Cell-Derived Extracellular Vesicle Therapy for Brain DisordersSection III Cell and Gene Therapy16. CARtalysts of Change: CAR T Cells at the Intersection of Engineering and Clinical Practice17. Prenatal Cell and Gene Therapy for Genetic Disorders18. Cell and Gene Therapies for Cardiovascular Disease 19. Monitoring Gene and Cell Therapies in Living Subjects with Molecular Imaging Technologies Index